IMTX (Immatics NV) SpecialCharges


IMTX Immatics NV IMTX
60 GF Score
Price $9.99
GF Value $3.41
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Immatics NV SpecialCharges?

Special Charges only applies to banks.

IMTX
60GF Score
Immatics NV IMTX
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Immatics NV (IMTX) Overvalued in 2026?

Based on GuruFocus' analysis, Immatics NV stock appears to be overvalued. The current stock price of $9.99 is trading 193% above its estimated GF Value™ of $3.41. GuruFocus considers Immatics NV to be Significantly Overvalued.

Key valuation signals for IMTX:

  • SpecialCharges:
  • GF Value™: $3.41 vs. price of $9.99 (193% above fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the IMTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Immatics NV Business Description

Other Exchanges 4A3:Germany
Address Paul-Ehrlich-Strasse 15, Tubingen, BW, DEU, 72076
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
60GF Score

Get the complete analysis for IMTX

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.99
Price
$3.41
GF Value